The Technology Feature 'Reading the second genomic code' (Nature 491, 143–147; 2012) wrongly stated that Constellation and Genentech are collaborating to develop inhibitors of BET proteins and EZH2 chromatin-writers. Although they are working together on inhibitor development, the targets are not those mentioned.
Additional information
The online version of the original article can be found at 10.1038/491143a
Rights and permissions
About this article
Cite this article
Correction. Nature 492, 297 (2012). https://doi.org/10.1038/492297a
Published:
Issue Date:
DOI: https://doi.org/10.1038/492297a
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
